logo-loader
LSE:GSK NYSE:GSK

GSK PLC

Receive alerts
Market:
LSE
Price
1707.60 GBX
Day Change
0.14%
Market Cap:
£69.72 b
52 weeks high
1719.80
52 weeks low
1302.60

In brief

GSK PLC will be a fully focused biopharma company following the demerger of its world-leading consumer healthcare business, Haleon, in July 2022. 

The company will prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease.